The associations of body mass index (BMI) and obesity with ovarian reserve are controversial. This systematic review and meta-analysis was conducted to investigate the associations in reproductive-aged women.
PubMed and Scopus were searched up to December, 2016. Original studies on the association of BMI with ovarian reserve markers, anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH), inhibin β, and antral follicle count (AFC), either according to BMI categories or a continuous variable, were selected. Analyses were stratified into three groups based on polycystic ovary syndrome (PCOS) and fertility status of women.
Of 4,055 records identified, 45 studies were eligible for inclusion. Comparing the obese with nonobese, the pooled mean differences (MDs) and 95% confidence intervals (CIs) were −1.08 (95% CIs −1.52, −0.63) ng/mL for AMH, −0.22 (95% CIs −0.39, −0.06) mIU/mL for FSH, −0.09 (95% CIs −0.60, 0.42) for AFC, and −21.06 (95% CIs −41.18, −0.85) pg/mL for inhibin β in overall populations. The MDs were significant for AMH in fertile non-PCOS and PCOS women, and for FSH only in PCOS women. Fisher's Z showed significant correlations of BMI with AMH in the overall populations (−0.15 [95% CIs −0.20, −0.11]) and in all subgroups, and with FSH in the fertile non-PCOS women (−0.16 [95% CIs −0.28, −0.04]).
Ovarian reserve markers of AMH and FSH are significantly lower in obese than in nonobese women, and BMI is negatively correlated with AMH in all study populations, and with FSH in fertile non-PCOS subgroups. PCOS and fertility status do not appear to affect the associations.
1Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
3Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Address correspondence to: Fahimeh Ramezani Tehrani, MD, No. 24, Shahid Arabi St, Yemen Blvd, Chamran Exp, P.O. Box 19395-4763, Tehran, Iran. E-mail: email@example.com; Parvin Mirmiran, PhD, No. 46, Arghavan-e-gharbi St., Farahzadi Blvd., Shahrak-e-qods, P.O. Box: 19395-4741, Tehran, Iran. E-mails: firstname.lastname@example.org, email@example.com
Received 6 February, 2018
Revised 15 March, 2018
Accepted 15 March, 2018
Funding/support: This study, as a part of Nazanin Moslehi's PhD thesis, was supported by Shahid Beheshti University of Medical Sciences (Grant No. 1396/D/4046-7).
Financial disclosure/conflicts of interest: None reported.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).